Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02555553 · ClinicalTrials.gov registry record · NA
Noom Monitor for Binge Eating
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 225
- Enrollment target
NCT02555553 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 225 participants.
The verdict
NCT02555553, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
Study Summary
The purpose of the proposed Phase II STTR study is to test the primary efficacy of a novel mobile app, 'Noom Monitor,' in a large population of binge eaters in the Kaiser Permanente health care system relative to a well-established treatment as usual (TAU) control condition. Noom Monitor facilitates the delivery of CBT-GSH by utilizing a patient interface that increases adherence and provides between-session reminders of CBT-GSH principles. In addition, the Noom Monitor includes a therapist interface with weekly feedback to the provider about patient progress. This application has several primary objectives, including: (1) testing the real-world effectiveness of the Noom Monitor in a clinical setting, and (2) establishing a database of training materials for Noom Monitor. The knowledge gained from the current study will contribute to our understanding of the role of new emerging mobile technologies in augmenting existing treatments.
Interventions
- BEHAVIORAL CBT-GSH with Noom Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02555553
The ClinicalTrials.gov registry entry for NCT02555553 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CBT-GSH with Noom Monitor is the first listed.
NCT02555553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02555553 about?
NCT02555553 is a clinical study titled "Noom Monitor for Binge Eating". The purpose of the proposed Phase II STTR study is to test the primary efficacy of a novel mobile app, 'Noom Monitor,' in a large population of binge eaters in the Kaiser Permanente health care system relative to a well-established treatment as usual (TAU) control condition. Noom Monitor facilitates...
What is the current status of trial NCT02555553?
This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2016-04. Estimated completion is 2018-05-01.
What interventions are being tested in trial NCT02555553?
The interventions under investigation include: CBT-GSH with Noom Monitor (BEHAVIORAL).
Who is sponsoring clinical trial NCT02555553?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.